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cleavages, the important role of AEP in
TLR9 signaling in DCs suggests that the
protease may be an attractive target for
pharmacological intervention in chronic
inflammatory diseases.
Even though the findings of Sepulveda
et al. (2009) are an important advance in
our understanding of TLR9 activation,
many questions remain to be answered.
Although all three relevant studies place
the site of TLR9 cleavage between resi-
dues 441 and 470 in a presumably disor-
dered loop in the ectodomain, the precise
cleavage site remains to be mapped.
Another critical question concerns the
molecular reason for TLR9 cleavage.
Given that full-length and truncated acti-
vated TLR9 both bind CpG DNA (though
with somewhat different affinity), proteo-
lytic cleavage may be required to allow
for conformational changes and/or TLR9
interaction with other proteins. Moreover,
much remains to be elucidated with
respect to TLR9 trafficking. Given that
only small amounts of full-length TLR9
reside in endosomes of steady-state
DCs, what signals trigger recruitment of
additional receptors to endolysosomes?
Although a positive-feedback mechanism
is conceivable, a role of additional nucleic
acid receptors cannot be ruled out.
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Polymorphonuclear neutrophil leukocytes (PMNs) have long been viewed as short-lived effector cells
capable of phagocytosing pathogens and mediating tissue damage. In this issue of Immunity, Zhang et al.
(2009) shed fresh light on the plasticity and immunoregulatory functions of PMNs.It is well known that polymorphonuclear
neutrophil leukocytes (PMNs) provide a
first line of defense against invading
pathogens by producing a wide range of
effector molecules essential for pathogen
killing (Nathan, 2006). In this issue of
Immunity, Zhang et al. (2009) report that
murine PMN might also display a pre-
viously unsuspected immunoregulatory
role during acute and chronic microbial
infections, thus extending current under-
standing in the field of PMN-derived
functions in response to PRR and other
microbial receptors.698 Immunity 31, November 20, 2009 ª2009PMNs capture and kill microbes
through production of reactive oxygen
species (ROS) and lytic enzymes with
potent antimicrobial activity and release
in the extracellular space of powerful
structures called neutrophil extracellular
traps, ‘‘NETs,’’ consisting of threads of
nuclear chromatin decorated with antimi-
crobial peptides and enzymes, including
bactericidal and permeability-increasing
proteins, neutrophil elastase, and cathep-
sin G, thus fulfilling their antimicrobial
function even beyond their life span
(Brinkmann et al., 2004). Because of theirElsevier Inc.powerful cytotoxic equipment, PMNs
have a major role in inflammatory re-
sponses. Indeed, when released in an
uncontrolled manner, as observed in
inflammatory diseases dominated by
PMNs, PMN-derived ROS and proteases
may also damage the surrounding tissues
(Nathan, 2006). However, increasing evi-
dence suggests that PMN are remarkably
versatile cells, whose functions go far be-
yond phagocytosis and pathogen killing.
For instance, exposure to an inflammatory
milieu dramatically increases the life span
of PMNs, thus giving them a chance to
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Previewsexpress more sophisticated regulatory
functions, including themigration to drain-
ing lymph nodes (Boudaly, 2009). More-
over, an additional and fascinating aspect
that has gradually come to light is the
regulated ability of PMN to synthesize a
number of cytokines and chemokines
involved in their effector functions (Cassa-
tella, 1999). Upon appropriate activa-
tion, human PMNs, in particular, have
been shown to produce chemokines as
well as proinflammatory, anti-inflamma-
tory, immunoregulatory, angiogenic, and
fibrogenic cytokines (Cassatella, 1999).
Although the ability of PMNs to transcribe
many genes is no longer a matter of
debate and may clearly enable these cells
to substantially influence not only the
multiple aspects of the inflammatory and
immune responses but also other func-
tions, including hematopoiesis, wound
healing, and antiviral defense, we are just
starting to appreciate their actual patho-
physiological relevance.
After pathogen encounter, cytokine
production by innate immune cells is trig-
gered by the activation of pattern recogni-
tion receptors (PRRs), a class of sensors
that recognize a limited set of conserved
molecular patterns unique to microbes,
the so-called pathogen-associated mo-
lecular patterns (PAMPs). PRR include:
(1) the Toll-like receptors (TLRs), which
signal via MyD88 (myeloid differentiation
factor 88)-dependent and-independent
pathways and are required for detection
of a broad range of microbial products;
(2) the nucleotide-binding oligomerization
domain (NOD) proteins, mostly recog-
nizing intracellular bacterial components;
and (3) the RNA helicases, which function
as intracellular sensors for viruses. An
additional large family of cell-surface
molecules with a carbohydrate recogni-
tion domain is represented by C-type lec-
tin receptors (CLRs), including CLEC-2
(CLEC-1B), CLEC4E (Mincle), CLEC5A
(MDL-1), CLEC7A (Dectin-1), and DCAR,
which directly or indirectly signal through
an immunoreceptor tyrosine-based acti-
vation motif (ITAM) and activate Syk-
dependent signaling pathways in innate
cells that mainly contribute to microbial
phagocytosis. By systematically ana-
lyzing highly purified cell populations iso-
lated from different murine tissues, Zhang
et al. (2009) demonstrate that PMNs can
be functionally activated in vitro by single
TLR, NLR and CLR agonists, as well as bythe entire pathogen (bacteria: mycobac-
teria, E. coli, S. flexneri; fungi: A. fumiga-
tus; viruses: influenza virus), yet without
producing substantial amounts of proin-
flammatory cytokines such as IL-12p40,
IL-1b, IL-6 or CXCL1 (Zhang et al., 2009)
(Figure 1). In contrast, the same stimula-
tory conditions are shown to trigger a large
production of the anti-inflammatory cyto-
kine IL-10 (Zhang et al., 2009). Consistent
with the essential role of p38 MAP and
PI3, Akt kinases in IL-10 production by
innate cells, cotriggering of TLR-MyD88-
and CLR-Syk-dependent pathways lead
to a rapid and sustained phosphorylation
of these two kinases in PMNs (Zhang
et al., 2009) (Figure 1). Interestingly, under
the same experimental conditions, autol-
ogous monocytes displayed a strong
proinflammatory cytokine profile and a
Akt NF-κBp38
MyD88DAP12, Syk
IL-10 Proinflammatory
cytokines
Immunoregulation
TLRCLR
Pathogen
NEUTROPHIL
Figure 1. Pattern Recognition and
Regulatory Function of Neutrophils
Classically, PMN interaction with pathogens trig-
gers a number of effector functions promoting
inflammation. The findings by Lo-Man and
colleagues demonstrate that in murine PMN
a Syk-MyD88-dependent pathway activated by
concomitant engagement of C-type lectin recep-
tors (CLRs) and Toll-like receptors (TLRs) induces
production of large amounts of the anti-inflamma-
tory cytokine IL-10 exerting immunoregulatory
functions.Immunity 31,relatively minor production of IL-10, con-
firming that, even in the mouse system,
the molecular mechanisms controlling re-
sponsiveness to TLRs and CLRs are cell
specific and subjected to distinct regula-
tory pathways in PMNs and monocytes
(Tamassia et al., 2007). Remarkably, the
capacity of murine PMNs to produce
IL-10 was fundamental in in vivo models
of mycobacterial infections. Through a
specific depletion strategy, the authors
demonstrated that PMNs negatively regu-
late local lung acute inflammation after
mucosal M. bovis infection via IL-10
release and counteract the control of my-
cobacterial burden during the chronic
phase of M. tuberculosis infection (Zhang
et al., 2009).
The report by Zhang et al. (2009) raises
a number of questions and suggests that
the role of PMN in inflammatory and infec-
tious conditions needs to be reconsidered
from a somewhat different, ‘‘regulatory’’
perspective. Such a reassessment will
necessarily involve the use of genetic ap-
proaches to deplete PMNs or inhibit their
functions in order to circumvent limita-
tions inherent to antibody-based elimina-
tion (i.e., rapid recovery, specificity, and
immune complexes-mediated effects).
Also the apparent discrepancy between
mouse and human PMNs in terms of
capacity to produce IL-10 and inflamma-
tory cytokines in response to PRR ligands
(Cassatella, 1999) requires further anal-
ysis, given its obvious implications for
humandiseases. For instance, cell density
is a keydeterminant for inflammatorycyto-
kine production in human PMN (M.A.C.,
unpublished data). Human PMNs and
monocytes have also recently shown to
express a selected microRNA repertoire
via aMyD88-dependent pathway (Bazzoni
et al., 2009) that might be ultimately
involved in regulating the expression of
selected cytokines. Here again, ‘‘in vivo
veritas’’ as well as appropriate genetic
approach will help to clarify the issue.
The present report also raises the ques-
tion as to the actual contribution of bona
fide PMNs or monocytes that are differen-
tiated from the expanded immature pro-
genitors to immunoregulation in tissues.
Infectious, neoplastic, and inflammatory
conditions are in fact associated with
the expansion of the myeloid compart-
ment with the appearance of a heteroge-
neous set of immunosuppressive cells
operationally defined as myeloid-derivedNovember 20, 2009 ª2009 Elsevier Inc. 699
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Previewssuppressor cells (Gabrilovich et al., 2007).
In this context, a recent report (Fridlender
et al., 2009) has indicated that murine
PMNs in tumors can undergo ‘‘N1’’ or
‘‘N2’’ polarization depending on mi-
croenvironmental cues such as TGF-b,
thus mirroring at least to some extent
the diversity of macrophage activation
and echoing the findings in the present
study. Whether IL-10 represents a major
cytokine produced by PMN-like MDSC
and/or N2-type PMNs infiltrating tumors
remains to be determined. In conclusion,
these studies call for a reappraisal of
the plasticity and regulatory functions ofInterleukin-17 Kick
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In this issue of Immunity, Lin et al.
immunity against Francisella tulare
T cell differentiation and function.
The immune system has evolved to pro-
tect an organism against a wide variety
of infectious agents, including viruses,
fungi, bacteria, and multicellular para-
sites. These pathogens employ many
different strategies to survive and multiply
in the host, which can lead directly or indi-
rectly to pathology because they interfere
with homeostasis or function of affected
cells and tissues. However, the immune
system is quite adept in facing and
handling the threats imposed by these
pathogens, using an array of specialized
cells and effector mechanisms. In this
issue of Immunity, Lin et al. (2009) de-
scribe a unique way in which the immune
system uses the strengths of two T cell
subsets to eliminate the intracellular path-
ogen Francisella tularensis.
T cells play an integral part in regulation
and execution of host defense. Generally
characterized by expression of the CD4
coreceptor, helper T cells are involved in
700 Immunity 31, November 20, 2009 ª2009PMNs in immune reactions and related
pathologies.
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(2009) implicate interleukin-17 in th
nsis. These findings add a unique
orchestrating the activities of the immune
system. Helper T cells can be categorized
in subpopulations that each are respon-
sible for a different task in the immune
response and are in fact educated to do
so. The basis of this concept was pro-
vided by the studies of Mosmann and
Coffman (1989), who observed that helper
T cells could be classified based on the
cytokines that they were able to produce
upon activation and that the observed
cytokine patterns were directly related to
the function of the respective T cell sub-
set. Thus, T helper 1 (Th1) cells produce
interferon-g (IFN-g), interleukin-2 (IL-2),
and lymphotoxin and are involved in
cellular immunity, whereas Th2 cells
produce IL-4, IL-5, IL-10, and IL-13 and
provide help for B cells in their activation
and differentiation leading to immuno-
globulin production and humoral immune
responses. Th1 cells provide help to cyto-
toxic CD8-positive T cells and macro-
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twist to the cytokine regulation of
phages to kill virus-infected cells and
cells infectedwith intracellular pathogens.
The production of immunoglobulin under
the control of Th2 cells is one of themech-
anisms that leads to elimination of extra-
cellular bacteria, and, through the IgE
mediated activation of mast cells, to pro-
tection against parasites. These concepts
have been refined in recent years with the
recognition of additional T cell subsets.
Regulatory T cells, either natural, induced,
or Tr1 cells, produce IL-10 and TGFb, sup-
press the activation of effector T cells, and
provide a counter-balance against uncon-
trolled and harmful T cell responses. Th9
cells may provide additional help for
mast cells through the production of IL-9.
And finally, an additional T cell subset
that produces IL-17A, IL-17F, IL-22, and
CCL20 was designated Th17 and has
been the focus of attention lately. The
cytokines that make up this subset’s
signature profile act on stromal and
